2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta …
L Ortega-Paz, M Galli, D Capodanno… - European Heart …, 2022 - academic.oup.com
Background The clinical impact of different prophylactic anticoagulation regimens among
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …
[HTML][HTML] ISTH guidelines for antithrombotic treatment in COVID‐19
S Schulman, M Sholzberg, AC Spyropoulos… - Journal of Thrombosis …, 2022 - Elsevier
Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
INSPIRATION-S Investigators - bmj, 2022 - bmj.com
Objective To assess the effect of statin treatment versus placebo on clinical outcomes in
patients with covid-19 admitted to the intensive care unit (ICU). Design INSPIRATION …
patients with covid-19 admitted to the intensive care unit (ICU). Design INSPIRATION …
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2022 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
Anticoagulation in COVID-19 patients–An updated systematic review and meta-analysis
S Reis, M Popp, S Schiesser, MI Metzendorf… - Thrombosis …, 2022 - Elsevier
Background Thromboembolic events are common complications of COVID-19. Clinical study
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among …
S Zuily, B Lefèvre, O Sanchez, OE de Vendin… - …, 2023 - thelancet.com
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …
Practical recommendations for optimal thromboprophylaxis in patients with COVID-19: a consensus statement based on available clinical trials
KG Kyriakoulis, E Dimakakos, IG Kyriakoulis… - Journal of clinical …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with
increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in …
increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in …
Step up to the platelet: role of platelets in inflammation and infection
A Carestia, LC Godin, CN Jenne - Thrombosis Research, 2022 - Elsevier
Platelets are anucleated cells derived from megakaryocytes that are primarily responsible
for hemostasis. However, in recent years, these cytoplasts have become increasingly …
for hemostasis. However, in recent years, these cytoplasts have become increasingly …